Key Speakers • Dr.Peter Adamson, Vice President and Head of Research Ophthiris, GlaxoSmithKline • Dr.Hans-Jürgen Wörle, Vice President, Therapeutic Area Head Metabolism, Boehringer Ingelheim Pharma GmbH & Co. KG • Dr. Michael Mark, Vice president, Therapeutic Area CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG • Dr. David H Solomon, President, Chief Executive Officer, Zealand pharma A/S • Dr.Steven Engle, Chairman and CEO, XOMA (US) LLC • Dr. Rob Jones, Senior Director, Medicinal Chemistry, Arena Pharmaceuticals • David M. Kendall, Chief Scientific and Medical Officer, American Diabetes Association • Dr. Araneo Barbara, Director of Complications Research, Juvenile Diabetes Research Foundation • Dr. Ennio Ongini, Vice President Research, NicOx • Dr. Selwyn Ho, Sr.Director, Marketing, Retina, Allergen EAME • Professor. P.M. Dodson, M.D, FRCP, FRCOphth Consultant, Diabetes & Medical Ophthalmology, Birmingham Heartlands Hospital, Birmingham, UK • Professor Sue Lightman, Professor of Clinical Ophthalmology and Consultant Ophthalmologist, Institute of Ophthalmology, University College London / Institute of Ophthalmology and Moorfields Eye Hospital • Alireza Falahati-Nini, M.D, FACE President, Utah Endocrinology Associates Medical Director, St. Mark’s Hospital Diabetes Center • Simon Taylor MA PhD FRCOphth, NIHR Clinical Lecturer in Ophthalmology, UCL Institute of Ophthalmology